Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Rafael Andreu"'
Autor:
Pau Abrisqueta, Eva González-Barca, Christelle Ferrà, Eduardo Ríos-Herranz, Margarita Fernández de la Mata, Julio Delgado, Rafael Andreu, José Ángel Hernández-Rivas, María José Terol, Almudena Navarro, M. Belén Vidriales, Patricia Baltasar, Javier De la Serna, Ángel Ramírez, Carmen Ballester, Carol Moreno, José Antonio García-Marco, Raúl Córdoba, Lucrecia Yáñez, Luís Felipe Casado, Marcos González, Francesc Bosch
Publikováno v:
EClinicalMedicine, Vol 73, Iss , Pp 102642- (2024)
Summary: Background: BTK inhibitors have been concurrently administered with anti-CD20 monoclonal antibodies (mAbs) in chronic lymphocytic leukemia (CLL). However, the optimal regimen for combining these two drugs remains pending. Methods: This multi
Externí odkaz:
https://doaj.org/article/0409832eb56e42f09c46046064da1b29
Autor:
Isabel Ródenas‐Quiñonero, Tzu Chen‐Liang, Taida Martín‐Santos, Antonio Salar, Marta Fernández‐González, Carolina Celades, José‐Tomás Navarro, Ana Belén Martínez‐Garcia, Rafael Andreu, Aitana Balaguer, Alejandro Martin García‐Sancho, Mónica Baile, Javier López‐Jiménez, Juan Marquet‐Palomanes, Ana Isabel Teruel, María José Terol, Carmen Benet, Laura Frutos, José Luis Navarro, Jon Uña, Marina Suarez, Montserrat Cortes, José Contreras, Cristina Ruiz, Pilar Tamayo, Jorge Mucientes, Pablo Sopena‐Novales, Laura Reguilón‐Gallego, José Javier Sánchez‐Blanco, Elena Pérez‐Ceballos, Andrés Jerez, Francisco José Ortuño
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 6536-6546 (2023)
Abstract Backgound In the workup of follicular lymphoma (FL), bone marrow biopsy (BMB) assessment is a key component of FLIPI and FLIPI2, the most widely used outcome scores. During the previous decade, several studies explored the role of FDG‐PET/
Externí odkaz:
https://doaj.org/article/45436750f28f45ad89c3293aff660252
Autor:
Rafael Andreu-Civit
Publikováno v:
Revista Empresa y Humanismo, Vol 26, Iss 1 (2023)
Una aportación fundamental de Juan Antonio Pérez López (en adelante JAPL) es un mejor entendimiento del proceso de interacción entre dos agentes, activo y reactivo, abriendo una nueva y productiva dimensión al análisis de las relaciones humanas
Externí odkaz:
https://doaj.org/article/2fe433bc9b79406b99f6915edb6a5da6
Autor:
Inmaculada Márquez, Gonzalo Pérez‐Mejías, Alejandra Guerra‐Castellano, José Luis Olloqui‐Sariego, Rafael Andreu, Juan José Calvente, Miguel A. De la Rosa, Irene Díaz‐Moreno
Publikováno v:
FEBS Open Bio, Vol 11, Iss 12, Pp 3304-3323 (2021)
Abstract Post‐translational modifications frequently modulate protein functions. Lysine acetylation in particular plays a key role in interactions between respiratory cytochrome c and its metabolic partners. To date, in vivo acetylation of lysines
Externí odkaz:
https://doaj.org/article/f09c544c2ba24db692de7b159c0df6a8
Autor:
Ana Muntañola, Guillermo Villacampa, José Ángel Hernández-Rivas, Rosalía Alonso, Fátima Mirás, Santiago Osorio, Mónica Baile, Patricia Baltasar, Javier López Jiménez, Ines Hernandez-Rodriguez, Susana Valenciano, Ana Alfayate, Eva Gimeno, Abelardo Bárez, Ana C. Oliveira, Rosalía Riaza, Pilar Romero, Julio Delgado, Lucrecia Yáñez, Amaya Zabalza, Ana Torres, Mª Isabel Gómez-Roncero, Marta Crespo, Raúl Córdoba, Juan José Mateos-Mazón, Sonia Pérez, Rafael Andreu, Jorge Labrador, Mª Elena Ruiz, César Andrés Velasquez, Mª José Terol, Raquel Santiago, Mª Jesús Vidal, Fiz Campoy García, Lucía Villalón, Begoña S. Muiña, Joan Alfons Soler, Cristina Seri, Mª José Sánchez, Amalia Cuesta, Rafael Ramos, Adrián Sánchez-Montalvá, Isabel Ruiz-Camps, Marcos González, Pau Abrisqueta, Francesc Bosch, of the GELLC (Grupo Español de Leucemia Linfática Crónica)
Publikováno v:
Experimental Hematology & Oncology, Vol 9, Iss 1, Pp 1-4 (2020)
Externí odkaz:
https://doaj.org/article/3cb4c5fec4404b34821a7fef7650fb2d
Autor:
Samuel Romero, Aitana Balaguer-Roselló, Juan Montoro, Paola Beneit, Amelia Martínez, Cristina Ruiz, Rafael Andreu, Manuel Guerreiro, Mario Arnao, Alberto Montava, Ana I. Vicente, Isidro Jarque, Jaime Sanz
Publikováno v:
Therapeutic Advances in Hematology, Vol 12 (2021)
The poor prognosis of refractory or relapsed (R/R) classical Hodgkin’s lymphoma (cHL) after autologous stem cell transplantation has improved greatly due to the introduction of brentuximab vedotin and PD-1 inhibitors. However, the duration of respo
Externí odkaz:
https://doaj.org/article/9fb9848f478d4320827170e5dea83428
Autor:
Mariam Ibáñez, Esperanza Such, Alessandro Liquori, Gayane Avestisyan, Rafael Andreu, Ana Vicente, María José Macián, Mari Carmen Melendez, Mireya Morote-Faubel, Pedro Asensi, María Pilar Lloret, Isidro Jarque, Isabel Picón, Alejandro Pacios, Eva Donato, Carmen Mas-Ochoa, Carmen Alonso, Carolina Cañigral, Amparo Sempere, Samuel Romero, Marta Santiago, Guillermo F. Sanz, Javier de la Rubia, Leonor Senent, Irene Luna
Publikováno v:
Diagnostics, Vol 12, Iss 4, p 953 (2022)
According to current guidelines, in chronic lymphocytic leukemia (CLL), only the TP53 molecular status must be evaluated prior to every treatment’s initiation. However, additional heterogeneous genetic events are known to confer a proliferative adv
Externí odkaz:
https://doaj.org/article/c1a36a4eb20143799aaa0bfe6a9b11c3
Autor:
José Luis Olloqui-Sariego, Inmaculada Márquez, Estrella Frutos-Beltrán, Irene Díaz-Moreno, Miguel A. De la Rosa, Juan José Calvente, Rafael Andreu, Antonio Díaz-Quintana
Publikováno v:
ACS Omega, Vol 3, Iss 9, Pp 11447-11454 (2018)
Externí odkaz:
https://doaj.org/article/1eb9f3a7a62c4e38a6bff0b43270e5f1
Autor:
Paolo Bollella, Massimo Marcaccio, Andrey Poloznikov, Dmitry Hushpulian, Rafael Andreu, Donal Leech, Lo Gorton, Riccarda Antiochia
Publikováno v:
Proceedings, Vol 1, Iss 8, p 699 (2017)
In the last few years, hydrogen peroxide [...]
Externí odkaz:
https://doaj.org/article/e5ab7e09965e465cb8da7ea8be37c111
Autor:
Alejandro Martín, Eulogio Conde, Montserrat Arnan, Miguel A. Canales, Guillermo Deben, Juan M. Sancho, Rafael Andreu, Antonio Salar, Pedro García-Sanchez, Lourdes Vázquez, Sara Nistal, María-José Requena, Eva M. Donato, José A. González, Ángel León, Concepción Ruiz, Carlos Grande, Eva González-Barca, María-Dolores Caballero
Publikováno v:
Haematologica, Vol 93, Iss 12 (2008)
Background The role of re-treatment with rituximab in aggressive B-cell lymphomas still needs to be defined. This study evaluated the influence of prior exposure to rituximab on response rates and survival in patients with diffuse large B-cell lympho
Externí odkaz:
https://doaj.org/article/c8e4e78a815b4aa99201d4747787f914